Checkpoint Therapeutics, Inc. (“Checkpoint” or the “Company”) (Nasdaq: CKPT), a Fortress Biotech (Nasdaq: FBIO) company, today announced the pricing of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE